Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

7(87.5%)

Phase 4

1(12.5%)

8Total

N/A(7)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT03689049Not ApplicableActive Not Recruiting

SPIDER: A Research & QI Collaboration Supporting Practices in Improving Care for Complex Elderly Patients

Role: collaborator

NCT02958800Not ApplicableCompleted

Deprescribing Antipsychotics in Long-Term Care

Role: collaborator

NCT04594200Not ApplicableCompleted

Do Fair Comparisons or Harms Data Increase Responsiveness to Feedback About Antibiotic Prescribing: 2x2 Factorial Trial

Role: collaborator

NCT05044052Not ApplicableCompleted

Does Inclusion of Viral Prescription Pad Resources Increase Responsiveness to Feedback About Antibiotic Prescribing in Primary Care

Role: collaborator

NCT00877344Phase 4Unknown

Better Contraceptive Choices: Immediate or Delayed Insertion of IUC After Second Trimester Abortion

Role: collaborator

NCT03312218Not ApplicableCompleted

The Study Guide Cluster Randomized Control Trial

Role: collaborator

NCT02382978Not ApplicableUnknown

Feasibility Study of Nurse-Provided Well Child Care

Role: collaborator

NCT00902031Not ApplicableCompleted

Effectiveness of Docusate in Preventing/Treating Constipation in Palliative Care Patients

Role: collaborator

All 8 trials loaded